 SCOTTSDALE, Ariz., March 19, 2021 GLOBE NEWSWIRE -- ELECTROMEDICAL TECHNOLOGIES, INC. OTCQB: EMED, a pioneer in the development and manufacturing of bioelectronic devices designed to relieve chronic, intractable and acute pains by using frequencies and electro-modulation, today issued the following statements regarding recent promotional activity concerning the Companys common stock, which was first brought to the Companys attention by OTC Markets. This press release is being issued as a result of a request from OTC Markets. 